Recruitment of the Diaphragm and Sternocleidomastoid Muscle During Loaded Inspiration on Varying Sitting Support in Healthy Adults
1 other identifier
observational
45
1 country
1
Brief Summary
This is a cross-sectional obsessional study. This study explores how different sitting conditions affect two important muscles-the diaphragm and the sternocleidomastoid (SCM)-work during breathing exercises. The diaphragm is the main muscle for breathing, while the SCM helps when taking deeper breaths. Understanding how these muscles interact while sitting under various conditions can help improve breathing training techniques. The study's objectives are (1) to investigate the relationship between diaphragm thickness fraction with 4 different sitting conditions during loaded inspiration among healthy adults and (2) To investigate the relationship between SCM activity with 4 different sitting conditions during loaded inspiration among healthy adults. This research will conduct healthy adults, who will be instructed to breathe against resistance provided by the IMT while sitting on four different conditions: a regular chair, a soft pad with feet on the ground, a soft pad with feet on two additional soft pads, and a single soft pad with both feet on one pad. By using ultrasound to measure how thick the diaphragm gets and surface electromyography (sEMG) to track SCM activity, the data will be gathered on how these muscles function under different conditions. The goal is to find out if sitting on unstable surfaces, like soft pads, can enhance diaphragm use compared to a stable chair. These surfaces may change how effectively the diaphragm and SCM work together. This research could lead to better recommendations for inspiratory muscle training (IMT), which helps strengthen these muscles, especially for people with breathing difficulties. By identifying how posture influences muscle recruitment during breathing exercises, hoping to contribute valuable insights that can improve rehabilitation programs for individuals with respiratory conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2025
CompletedFirst Posted
Study publicly available on registry
June 6, 2025
CompletedStudy Start
First participant enrolled
June 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2026
CompletedJune 6, 2025
May 1, 2025
1 month
May 10, 2025
June 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diaphragmatic thickening fraction
Diaphragmatic thickening fraction is determined by "(thickness of the diaphragm at end inspiratory - thickness at end expiratory)/thickness at end expiratory". Diaphragmatic thickness will be measured by ultrasonography.
Through study completion, an average of 1 year
Secondary Outcomes (2)
Muscle activation of the sternocleidomastoid muscle
Through study completion, an average of 1 year
Borg's scale
Through study completion, an average of 1 year
Other Outcomes (1)
The Short Form (12) Health Survey
Through study completion, an average of 1 year
Eligibility Criteria
aged 18-35 healthy young adults
You may qualify if:
- aged 18-35 years - No recent thoracic surgery in the past 6 months
- Absence in history of chronic respiratory illness
- Able to breathe spontaneously
- Conscious, able to follow instructions on the use of IMT device
You may not qualify if:
- with known cardiovascular, pulmonary or musculoskeletal disorders that would limit their functional capacity (E.g. Asthma, COPD)
- presence with respiratory symptoms over past 2 weeks
- pregnancy
- malignancy
- presence of neurological disorders (e.g. ALS, stroke)
- PCS/ MCS in SF-12 scores below 50
- Findings in spirometry suggesting presence of obstructive or restrictive disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hong Kong Metropolitan University Jockey Club Institute of Healthcare
Hong Kong, Hong Kong
Study Officials
- STUDY DIRECTOR
William Tsang
Hong Kong Metropolitan University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PHD student
Study Record Dates
First Submitted
May 10, 2025
First Posted
June 6, 2025
Study Start
June 19, 2025
Primary Completion
July 31, 2025
Study Completion
April 20, 2026
Last Updated
June 6, 2025
Record last verified: 2025-05